Skip to main content

sec filings

Insider trades

Open-market buys and sales that company insiders report to the SEC on .

Side
Planned sales
Role
LXEO

Updated 10/6/2026, 11:57 AM ET.

LXEO

Lexeo Therapeutics, Inc.

Sale$20,203

Tamayo Louis Edward

Chief Financial Officer

4,117 shat $4.91Filed Aug 19, 5:00 PM ETFiling
LXEO

Lexeo Therapeutics, Inc.

Sale$16,562

Townsend Richard Nolan

Chief Executive Officer, Director

3,345 shat $4.95Filed Aug 19, 5:00 PM ETFiling
LXEO

Lexeo Therapeutics, Inc.

Sale$6,464

Otero Jose Manuel

Chief Operating Officer

1,304 shat $4.96Filed Aug 19, 5:00 PM ETFiling

Read from public SEC filings. Not financial advice.